Advertisement

Association between DNA methylation and coronary heart disease or other atherosclerotic events: A systematic review

  • Alba Fernández-Sanlés
    Affiliations
    Cardiovascular Epidemiology and Genetics Research Group, REGICOR Study Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Catalonia, Spain

    Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain
    Search for articles by this author
  • Sergi Sayols-Baixeras
    Affiliations
    Cardiovascular Epidemiology and Genetics Research Group, REGICOR Study Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Catalonia, Spain

    Universitat Pompeu Fabra (UPF), Barcelona, Catalonia, Spain

    CIBER Cardiovascular Diseases (CIBERCV), Barcelona, Catalonia, Spain
    Search for articles by this author
  • Isaac Subirana
    Affiliations
    Cardiovascular Epidemiology and Genetics Research Group, REGICOR Study Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Catalonia, Spain

    CIBER Epidemiology and Public Health (CIBERESP), Barcelona, Catalonia, Spain
    Search for articles by this author
  • Irene R. Degano
    Affiliations
    Cardiovascular Epidemiology and Genetics Research Group, REGICOR Study Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Catalonia, Spain

    CIBER Cardiovascular Diseases (CIBERCV), Barcelona, Catalonia, Spain
    Search for articles by this author
  • Roberto Elosua
    Correspondence
    Corresponding author. IMIM, Hospital del Mar Medical Research Institute, Dr Aiguader 88, 08003 Barcelona, Catalonia, Spain.
    Affiliations
    Cardiovascular Epidemiology and Genetics Research Group, REGICOR Study Group, IMIM (Hospital Del Mar Medical Research Institute), Barcelona, Catalonia, Spain

    CIBER Cardiovascular Diseases (CIBERCV), Barcelona, Catalonia, Spain
    Search for articles by this author

      Highlights

      • Global DNA methylation does not seem to be associated with CHD.
      • Candidate-gene studies proved four genes to be differentially methylated in CHD.
      • A set of 84 genes has been identified in at least two EWAS.
      • This set of genes could be prioritized in future analysis.
      • The EWAS results highlight the role of obesity, metabolism or inflammation in CHD.

      Abstract

      Background and aims

      The aim of this study was to perform a systematic review of the association between DNA methylation and coronary heart disease (CHD) or related atherosclerotic traits.

      Methods

      A systematic review was designed. The condition of interest was DNA methylation, and the outcome was CHD or other atherosclerosis-related traits. Three DNA methylation approaches were considered: global methylation, candidate-gene, and epigenome-wide association studies (EWAS). A functional analysis was undertaken using the Ingenuity Pathway Analysis software.

      Results

      In total, 51 articles were included in the analysis: 12 global methylation, 34 candidate-gene and 11 EWAS, with six studies using more than one approach. The results of the global methylation studies were inconsistent. The candidate-gene results were consistent for some genes, suggesting that hypermethylation in ESRα, ABCG1 and FOXP3 and hypomethylation in IL-6 were associated with CHD. The EWAS identified 84 genes showing differential methylation associated with CHD in more than one study. The probability of these findings was <1.37·10−5. One third of these genes have been related to obesity in genome-wide association studies. The functional analysis identified several diseases and functions related to these set of genes: inflammatory, metabolic and cardiovascular disease.

      Conclusions

      Global DNA methylation seems to be not associated with CHD. The evidence from candidate-gene studies was limited. The EWAS identified a set of 84 genes highlighting the relevance of obesity, inflammation, lipid and carbohydrate metabolism in CHD. This set of genes could be prioritized in future studies assessing the role of DNA methylation in CHD.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • WHO
        Global Status Report on Noncommunicable Diseases.
        2014
        • Arora M.
        • Barber R.M.
        • et al.
        • GBD 2015 DALYs and HALE Collaborators
        Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the global burden of disease study 2015.
        Lancet. 2016; 388: 1603-1658
      1. M. Neidhart. DNA methylation in cardiology, in: DNA Methylation Complex Human Disease, 2016:261–272.

        • Wolffe A.P.
        • Matzke M.A.
        Epigenetics: regulation through repression.
        Science. 1999; 286: 481-486
        • Little J.
        • Higgins J.P.
        • Ioannidis J.P.
        • et al.
        STrengthening the REporting of Genetic Association studies (STREGA)— an extension of the STROBE statement.
        PLoS Med. 2009; 6: e1000022
        • Castro R.
        • Rivera I.
        • Struys E.A.
        • et al.
        Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease.
        Clin. Chem. 2003; 49: 1292-1296
        • Watson C.J.
        • Collier P.
        • Tea I.
        • et al.
        Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype.
        Hum. Mol. Genet. 2014; 23: 2176-2188
        • Huica I.
        • Botezatu A.
        • Iancu I.V.
        • et al.
        Genetic and epigenetic aspects in cardio-vascular disease and ageing.
        Rom. Biotechnol. Lett. 2011; 16: 6488-6496
        • Talens R.P.
        • Jukema J.W.
        • Trompet S.
        • et al.
        Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction.
        Int. J. Epidemiol. 2012; 41: 106-115
        • Friso S.
        • Lotto V.
        • Choi S.-W.
        • et al.
        Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease.
        J. Med. Genet. 2012; 49: 192-199
        • Fiorito G.
        • Guarrera S.
        • Valle C.
        • et al.
        B-vitamins intake, DNA-methylation of one carbon metabolism and homocysteine pathway genes and myocardial infarction risk: the EPICOR study.
        Nutr. Metab. Cardiovasc. Dis. 2014; 24: 483-488
        • Pfeiffer L.
        • Wahl S.
        • Pilling L.C.
        • et al.
        DNA methylation of lipid-related genes affects blood lipid levels.
        Circ. Cardiovasc. Genet. 2015; 8: 334-342
        • Murray R.
        • Bryant J.
        • Titcombe P.
        • et al.
        DNA methylation at birth within the promoter of ANRIL predicts markers of cardiovascular risk at 9 years.
        Clin. Epigenetics. 2016; 8: 90
        • Perna L.
        • Zhang Y.
        • Mons U.
        • et al.
        Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort.
        Clin. Epigenetics. 2016; 8: 64
        • Zaina S.
        • Heyn H.
        • Carmona F.J.
        • et al.
        DNA methylation map of human atherosclerosis.
        Circ. Cardiovasc. Genet. 2014; 7: 692-700
        • Ek W.E.
        • Hedman A.K.
        • Enroth S.
        • et al.
        Genome-wide DNA methylation study identifies genes associated with the cardiovascular biomarker GDF-15.
        Hum. Mol. Genet. 2016; 25: 817-827
        • Guarrera S.
        • Fiorito G.
        • Onland-Moret N.C.
        • et al.
        Gene-specific DNA methylation profiles and LINE-1 hypomethylation are associated with myocardial infarction risk.
        Clin. Epigenetics. 2015; 7: 133
        • Oudejans C.
        • Poutsma A.
        • Michel O.
        • et al.
        Genome-wide identification of epigenetic hotspots potentially related to cardiovascular risk in adult women after a complicated pregnancy.
        PLoS One. 2016; 11: e0148313
        • Rask-Andersen M.
        • Martinsson D.
        • Ahsan M.
        • et al.
        Epigenome-wide association study reveals differential DNA methylation in individuals with a history of myocardial infarction.
        Hum. Mol. Genet. 2016; https://doi.org/10.1093/hmg/ddw302
        • Gómez-Uriz A.M.
        • Goyenechea E.
        • Campión J.
        • et al.
        Epigenetic patterns of two gene promoters (TNF-α and PON) in stroke considering obesity condition and dietary intake.
        J. Physiol. Biochem. 2014; 70: 603-614
        • Gómez-Úriz A.M.
        • Milagro F.I.
        • Mansego M.L.
        • et al.
        Obesity and ischemic stroke modulate the methylation levels of KCNQ1 in white blood cells.
        Hum. Mol. Genet. 2015; 24: 1432-1440
        • Zhang Y.
        • Yang R.
        • Burwinkel B.
        • et al.
        F2RL3 methylation in blood DNA is a strong predictor of mortality.
        Int. J. Epidemiol. 2014; 43: 1215-1225
        • Kim M.
        • Long T.I.
        • Arakawa K.
        • et al.
        DNA methylation as a biomarker for cardiovascular disease risk.
        PLoS One. 2010; 5: 1-8
        • Huang Y.S.
        • Zhi Y.F.
        • Wang S.R.
        Hypermethylation of estrogen receptor-alpha gene in atheromatosis patients and its correlation with homocysteine.
        Pathophysiology. 2009; 16: 259-265
        • Zhuang J.
        • Peng W.
        • Li H.
        • et al.
        Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.
        PLoS One. 2012; 7: e47193
        • Jiang D.
        • Zheng D.
        • Wang L.
        • et al.
        Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females.
        PLoS One. 2013; 8: 1-7
        • Lü C.
        • Xu R.
        • Cao M.
        • et al.
        FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.
        Atherosclerosis. 2013; 229: 263-270
        • Xu L.
        • Zheng D.
        • Wang L.
        • Jiang D.
        • Liu H.
        • Xu L.
        • Liao Q.
        • Zhang L.
        • Liu P.
        • Shi X.
        • Wang Z.
        • Sun L.
        • Zhou Q.
        • Li N.
        • Huang Y.
        • Le Y.
        • Ye M.
        • Shao G.
        • Duan S.
        GCK gene-body hypomethylation is associated with the risk of coronary heart disease.
        Biomed. Res. Int. 2014; 2014 (http://dx.doi.org/10.1155/2014/151723 151723)
        • Niu P.-P.
        • Cao Y.
        • Gong T.
        • et al.
        Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients.
        J. Transl. Med. 2014; 12: 170
        • Peng P.
        • Wang L.
        • Yang X.
        • et al.
        A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease.
        PLoS One. 2014; 9: 8-15
        • Yang Q.
        • Zhao Y.
        • Zhang Z.
        • Chen J.
        Association of interleukin-6 methylation in leukocyte DNA with serum level and the risk of ischemic heart disease.
        Scand. J. Clin. Lab. Invest. 2016; 76: 291-295
        • Zuo H.
        • Guo Y.
        • Che L.
        • Wu X.
        Hypomethylation of Interleukin-6 promoter is associated with the risk of coronary heart disease.
        Arq. Bras. Cardiol. 2016; 107: 131-136
        • Jia L.
        • Zhu L.
        • Wang J.Z.
        • et al.
        Methylation of FOXP3 in regulatory T cells is related to the severity of coronary artery disease.
        Atherosclerosis. 2013; 228: 346-352
        • Wei L.
        • Liu S.
        • Su Z.
        • et al.
        LINE-1 hypomethylation is associated with the risk of coronary heart disease in Chinese population.
        Arq. Bras. Cardiol. 2014; 102: 481-488
        • Zhong J.
        • Chen X.
        • Wu N.
        • et al.
        Catechol-O-methyltransferase promoter hypomethylation is associated with the risk of coronary heart disease.
        Exp. Ther. Med. 2016; 12: 3445-3449
        • Lin R.-T.
        • Hsi E.
        • Lin H.-F.
        • et al.
        LINE-1 methylation is associated with an increased risk of ischemic stroke in men.
        Curr. Neurovasc. Res. 2014; 11: 4-9
        • Ying A.K.
        • Hassanain H.H.
        • Roos C.M.
        • et al.
        Methylation of the estrogen receptor-a gene promoter is selectively increased in proliferating human aortic smooth muscle cells.
        Cardiovasc. Res. 2000; 46: 172-179
        • Post W.S.
        • Goldschmidt-Clermont P.J.
        • Wilhide C.C.
        • et al.
        Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system.
        Cardiovasc. Res. 1999; 43: 985-991
        • Zhu S.
        • Goldschmidt-Clermont P.J.
        • Dong C.
        Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis.
        Circulation. 2005; 112: 1353-1361
        • Zhao J.
        • Forsberg C.W.
        • Goldberg J.
        • et al.
        MAOA promoter methylation and susceptibility to carotid atherosclerosis: role of familial factors in a monozygotic twin sample.
        BMC Med. Genet. 2012; 13: 100
        • Horvath S.
        • Gurven M.
        • Levine M.E.
        • et al.
        An epigenetic clock analysis of race/ethnicity, sex, and coronary heart disease.
        Genome Biol. 2016; 17: 171
        • Baccarelli A.
        • Wright R.
        • Bollati V.
        • et al.
        Ischemic heart disease and stroke in relation to blood DNA methylation.
        Epidemiology. 2010; 21: 819-828
        • Sharma P.
        • Kumar J.
        • Garg G.
        • et al.
        Detection of altered global DNA methylation in coronary artery disease patients.
        DNA Cell Biol. 2008; 27: 357-365
        • Sharma P.
        • Garg G.
        • Kumar A.
        • et al.
        Genome wide DNA methylation profiling for epigenetic alteration in coronary artery disease patients.
        Gene. 2014; 541: 31-40
        • Lakshmi S.V.V.
        • Naushad S.M.
        • Reddy C.A.
        • et al.
        Oxidative stress in coronary artery disease: epigenetic perspective.
        Mol. Cell. Biochem. 2013; 374: 203-211
        • Guay S.-P.
        • Légaré C.
        • Houde A.-A.
        • et al.
        Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men.
        Clin. Epigenetics. 2014; 6: 14
        • Nguyen A.
        • Mamarbachi M.
        • Turcot V.
        • et al.
        Lower methylation of the ANGPTL2 gene in leukocytes from post-acute coronary syndrome patients.
        PLoS One. 2016; 11: 1-17
        • Yamada Y.
        • Nishida T.
        • Horibe H.
        Identification of hypo- and hypermethylated genes related to atherosclerosis by a genome-wide analysis of DNA methylation.
        Int. J. Mol. Med. 2014; 33: 1355-1363
        • Wei L.K.
        • Sutherland H.
        • Au A.
        • Camilleri E.
        • Haupt L.M.
        • Gan S.H.
        • Griffiths L.R.
        A potential epigenetic marker mediating serum folate and vitamin B12 levels contributes to the risk of ischemic stroke.
        Biomed. Res. Int. 2015; 2015 (167976 http://dx.doi.org/10.1155/2015/167976)
        • Afzali M.
        • Nakhaee A.
        • Tabatabaei S.P.
        • et al.
        Aberrant promoter methylation profile of niemann-pick type C1 gene in cardiovascular disease.
        Iran. Biomed. J. 2013; 17: 77-83
        • Nazarenko M.S.
        • Markov A.V.
        • Lebedev I.N.
        • et al.
        A comparison of genome-wide DNA methylation patterns between different vascular tissues from patients with coronary heart disease.
        PLoS One. 2015; 10: 1-15
        • Ramos R.B.
        • Fabris V.
        • Lecke S.B.
        • et al.
        Association between global leukocyte DNA methylation and cardiovascular risk in postmenopausal women.
        BMC Med. Genet. 2016; 17: 71
        • Castillo-Díaz S.A.
        • Garay-Sevilla M.E.
        • Hernández-González M.A.
        • et al.
        Extensive demethylation of normally hypermethylated CpG islands occurs in human atherosclerotic arteries.
        Int. J. Mol. Med. 2010; 26: 691-700
        • Kim J.
        • Kim J.Y.
        • Song K.S.
        • et al.
        Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence.
        Biochim. Biophys. Acta. 2007; 1772: 72-80
        • Connelly J.J.
        • Cherepanova O.A.
        • Doss J.F.
        • et al.
        Epigenetic regulation of COL15A1 in smooth muscle cell replicative aging and atherosclerosis.
        Hum. Mol. Genet. 2013; 22: 5107-5120
        • Baccarelli A.A.
        • Byun H.-M.
        Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease.
        Clin. Epigenetics. 2015; 7: 44
        • Muka T.
        • Koromani F.
        • Portilla E.
        • et al.
        The role of epigenetic modifications in cardiovascular disease: a systematic review.
        Int. J. Cardiol. 2016; 212: 174-183
        • Muka T.
        • Nano J.
        • Voortman T.
        • et al.
        The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: a systematic review.
        Nutr. Metab. Cardiovasc. Dis. 2016; 26: 553-566
        • Braun K.V.E.
        • Voortman T.
        • Dhana K.
        • et al.
        The role of DNA methylation in dyslipidaemia: a systematic review.
        Prog. Lipid Res. 2016; 64: 178-191
        • Wu H.C.
        • Delgado-Cruzata L.
        • Flom J.D.
        • et al.
        Global methylation profles in DNA from different blood cell types.
        Epigenetics. 2011; 6: 76-85
        • Soriano-Tárraga C.
        • Jiménez-Conde J.
        • Giralt-Steinhauer E.
        • et al.
        DNA isolation method is a source of global DNA methylation variability measured with LUMA. Experimental analysis and a systematic review.
        PLoS One. 2013; 8: e60750
        • Jones P.A.
        Functions of DNA methylation: islands, start sites, gene bodies and beyond.
        Nat. Rev. Genet. 2012; : 13484-13492
        • Lu Q.
        • Schnitzler G.R.
        • Vallaster C.S.
        • et al.
        Unliganded estrogen receptor alpha regulates vascular cell function and gene expression.
        Mol. Cell. Endocrinol. 2017; 442: 12-23
        • Rosenson R.S.
        • Brewer H.B.
        • Ansell B.J.
        • et al.
        Dysfunctional HDL and atherosclerotic cardiovascular disease.
        Nat. Rev. Cardiol. 2016; 13: 48-60
        • Anderson D.R.
        • Poterucha J.T.
        • Mikuls T.R.
        • et al.
        IL-6 and its receptors in coronary artery disease and acute myocardial infarction.
        Cytokine. 2013; 62: 395-400
        • Meng X.
        • Yang J.
        • Dong M.
        • et al.
        Regulatory T cells in cardiovascular diseases.
        Nat. Rev. Cardiol. 2016; 13: 167-179
        • Baron U.
        • Floess S.
        • Wieczorek G.
        • et al.
        DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells.
        Eur. J. Immunol. 2007; 37: 2378-2389
        • Mahley R.W.
        Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders.
        J. Mol. Med. 2016; 94: 739-746
        • Michels K.B.
        • Binder A.M.
        • Dedeurwaerder S.
        • et al.
        Recommendations for the design and analysis of epigenome-wide association studies.
        Nat. Methods. 2013; 10: 949-955
        • Bae J.
        • Leo C.P.
        • Hsu S.Y.
        • Hsueh A.J.
        MCL-1S, a splicing variant of the antiapoptotic BCL-2 family member MCL-1, encodes a proapoptotic protein possessing only the BH3 domain.
        J. Biol. Chem. 2000; 275: 25255-25261
        • Bingle C.D.
        • Craig R.W.
        • Swales B.M.
        • et al.
        Exon skipping in Mcl-1 results in a bcl-2 homology domain 3 only gene product that promotes cell death.
        J. Biol. Chem. 2000; 275: 22136-22146
        • Van Vré E.A.
        • Ait-Oufella H.
        • Tedgui A.
        • Mallat Z.
        Apoptotic cell death and efferocytosis in atherosclerosis.
        Arterioscler. Thromb. Vasc. Biol. 2012; 32: 887-893
        • Halvorsen B.
        • Waehre T.
        • Scholz H.
        • et al.
        Interleukin-10 enhances the oxidized LDL-induced foam cell formation of macrophages by antiapoptotic mechanisms.
        J. Lipid Res. 2005; 46: 211-219
        • Hakimi M.
        • Peters A.
        • Becker A.
        • Böckler D.
        • Dihlmann S.
        Inflammation-related induction of absent in melanoma 2 (AIM2) in vascular cells and atherosclerotic lesions suggests a role in vascular pathogenesis.
        J. Vasc. Surg. 2014; 59 (e2): 794-803
        • Papaspyridonos M.
        • Smith A.
        • Burnand K.G.
        • et al.
        Novel candidate genes in unstable areas of human atherosclerotic plaques.
        Arterioscler. Thromb. Vasc. Biol. 2006; 26: 1837-1844
        • Puig O.
        • Yuan J.
        • Stepaniants S.
        • et al.
        A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.
        Circ. Cardiovasc. Genet. 2011; 4: 595-604
        • Norris J.M.
        • Langefeld C.D.
        • Talbert M.E.
        • et al.
        Genome-wide association study and follow-up analysis of adiposity traits in hispanic americans: the IRAS family study.
        Obesity. 2009; 17: 1932-1941
        • Kim H.-J.
        • Park J.-H.
        • Lee S.
        • et al.
        A common variant of NGEF is associated with abdominal visceral fat in Korean men.
        PLoS One. 2015; 10: e0137564
        • Tan M.
        • Hao F.
        • Xu X.
        • Chisolm G.M.
        • Cui M.-Z.
        Lysophosphatidylcholine activates a novel PKD2-mediated signaling pathway that controls monocyte migration.
        Arterioscler. Thromb. Vasc. Biol. 2009; 29: 1376-1382
        • Yamada S.
        • Wang K.-Y.
        • Tanimoto A.
        • Sasaguri Y.
        Novel function of histamine signaling in hyperlipidemia-induced atherosclerosis: histamine H1 receptors protect and H2 receptors accelerate atherosclerosis.
        Pathol. Int. 2015; 65: 67-80
        • Modjeski K.L.
        • Ture S.K.
        • Field D.J.
        • et al.
        Glutamate receptor interacting protein 1 mediates platelet adhesion and thrombus formation.
        PLoS One. 2016; 11: e0160638
        • Karpe F.
        • Pinnick K.E.
        Biology of upper-body and lower-body adipose tissue–link to whole-body phenotypes.
        Nat. Rev. Endocrinol. 2015; 11: 90-100
        • Sayols-Baixeras S.
        • Hernáez A.
        • Subirana I.
        • et al.
        DNA methylation and high-density lipoprotein functionality.
        Arterioscler. Thromb. Vasc. Biol. 2017; 37: 567-569
        • Mandviwala T.
        • Khalid U.
        • Deswal A.
        Obesity and cardiovascular disease: a risk factor or a risk marker?.
        Curr. Atheroscler. Rep. 2016; 18: 21
        • Grundy S.M.
        Metabolic syndrome update.
        Trends Cardiovasc. Med. 2016; 26: 364-373